Ads
related to: tyrosine kinase
Search results
The Key to Finding Predictive Biomarkers in Metastatic Renal Cell Carcinoma?
MedPage Today· 19 hours agoIn fact, predictive biomarkers that are routinely used in other solid malignancies, including...
BMS and Zai Lab’s Augtyro gains NMPA approval to treat NSCLC
Pharmaceutical Technology via Yahoo Finance· 18 hours agoAugtyro, an orally administered tyrosine kinase inhibitor (TKI) designed to inhibit specific kinases...
Opinion | Ending Oncology's Toxic Relationship With High Chemotherapy Doses
MedPage Today· 4 days agoIn my practice, which focuses exclusively on treating patients with leukemias and related myeloid...
Atria Wealth Solutions Inc. Takes $214,000 Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
ETF DAILY NEWS· 3 days agoAtria Wealth Solutions Inc. acquired a new position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) in the 4th quarter, according to the company in its most recent filing with ...
Apollomics (NASDAQ:APLM) PT Lowered to $2.00 at HC Wainwright
ETF DAILY NEWS· 3 days agoApollomics (NASDAQ:APLM – Free Report) had its price objective trimmed by HC Wainwright from $5.00 to $2.00 in a research note issued to investors on Wednesday morning, Benzinga reports. The ...
Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and...
FOX21 Colorado Springs· 5 days agoKyowa Kirin Co., Ltd. (TSE: 4151) today announced that data from the pre-clinical pharmacokinetics & efficacy study comparing ocular tissue distribution after ocular instillation of tivozanib ...
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
Motley Fool via Yahoo Finance· 2 days agoIts two most important markets are renal cell carcinoma (RCC, a type of kidney cancer) and...
Diagnosing Multiple Sclerosis: 5 Things to Know
Medscape· 5 days agoIn the United States, nearly 1 million people are living with multiple sclerosis (MS), an immune-mediated inflammatory disease that causes demyelination...
Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments
The Pendulum· 5 days agoCash, cash equivalents, marketable securities and restricted cash totaled approximately $287.6 million on March 31, 2024, which excludes the net proceeds of approximately $247.8 million from Biohaven's public offering completed
Getting to know the enzymes behind cell communication—and tumor growth
Phys.org· 6 days agoKinases are enzymes that facilitate a process called phosphorylation. In cases that involve proteins, a protein kinase recruits a piece of a molecule called a phosphate group (a molecular fragment ...
